ArticlePediatric surgery international2026
Pulse pressure as an early mortality predictor in neonates with congenital diaphragmatic hernia on veno-arterial ECMO.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEarly prognostic markers for pediatric patients receiving extracorporeal membrane oxygenation (ECMO), particularly those with congenital diaphragmatic hernia (CDH), remain poorly defined. This study aimed to evaluate pulse pressure (PP) as an early hemodynamic indicator of mortality in neonates with CDH undergoing veno-arterial (VA) ECMO.
methodsWe retrospectively analyzed newborns who underwent VA ECMO as primary rescue therapy for isolated CDH. Perinatal characteristics, arterial blood gas parameters, and blood pressure (BP) during the first 48 h post-ECMO were evaluated and compared between survivors and non-survivors.
resultsAmong 33 neonates, 20 (60.6%) survived. ECMO flow rates or systolic, diastolic, and mean BP did not differ between the group. However, PP at 24 h (20.0 mmHg [17.8-26.3] vs. 12.0 mmHg [10.0-13.0], p < 0.001) and 48 h (24.0 mmHg [20.0-28.8] vs. 12.0 mmHg [10.0-14.0], p < 0.001) post-ECMO was significantly higher in survivors. Receiver operating characteristic analysis demonstrated that PP was am early predictor of survival, with optimal cutoff values of 20 mmHg at 24 h and 17 mmHg at 48 h.
conclusionEarly recovery of PP was a strong predictor of survival in neonates with CDH requiring VA-ECMO. Further research is required to determine whether interventions to enhance pulsatility can improve clinical outcomes in this high-risk population.
Indexed as
Identifiers
42467251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.